Based on the status of ER, PR, Ki-67 and HER2 (ERBB2), BC characterized by significant heterogeneity can be categorized into four major subtypes, namely, luminal A, luminal B, HER2-positive and triple-negative breast cancer (TNBC) [3]. This evidence concerns the gene ERBB2 and breast cancer.